Clinical Trial Update: Pamidronate to Treat Osteogenesis Imperfecta in Children [Phase 3]

View source ↗

Summary

Phase 3 trial of pamidronate in children with osteogenesis imperfecta has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Pamidronate disodium (Aredia) (pamidronate disodium)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Osteogenesis Imperfecta | Phase 3 | Status: COMPLETED | Results posted: 2016-03-01